A carregar...
Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells
Two major barriers in the immunotherapy of breast cancer include tumor-induced immune suppression and the establishment of long-lasting immune responses against the tumor. Recently, we demonstrated in an animal model of breast carcinoma that expanding and reprogramming tumor-sensitized lymphocytes,...
Na minha lista:
Publicado no: | Breast Cancer Res Treat |
---|---|
Main Authors: | , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2013
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4844228/ https://ncbi.nlm.nih.gov/pubmed/24197563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-013-2733-5 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|